The author replies

New England Journal of Medicine

Volumn 365, Issue 16, 2011, Pages 1543-1544

  Madhi, Shabir A ^a   Kim, Soyeon ^b   Mitchell, Charles ^c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PLACEBO;

CHILD CARE; CHILD HEALTH; DRUG EFFICACY; DRUG SAFETY; HUMAN; IMMUNOCOMPROMISED PATIENT; INCIDENCE; LETTER; LUNG TUBERCULOSIS; MORTALITY; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; TUBERCULIN TEST;

EID: 80054760659     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1109603     Document Type: Letter

References (3)

1. Cotton MF, Wasserman E, Smit J, Whitelaw A, Zar HJ. High incidence of antimicrobial resistant organisms including extended spectrum beta-lactamase producing Enterobacteriaceae and methicillin-resistant Staphylococcus aureus in nasopharyngeal and blood isolates of HIV-infected children from Cape Town, South Africa. BMC Infect Dis 2008;8:40.
2. Marais BJ, Gie RP, Schaaf HS, et al. The natural history of childhood intra-thoracic tuberculosis: a critical review of literature from the pre-chemotherapy era. Int J Tuberc Lung Dis 2004; 8:392-402. (Pubitemid 38624845)
3. Nachman S, Zeldow B, Dittmer S, et al. Lack of identification of adult TB contacts in infants with microbiologically confirmed or clinically presumed TB (MCCP TB) in clinical trial P1041. Presented at the 6th International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention, Rome, July 17-20, 2011. abstract.